Health
Factlen Explainer
Scientists Identify New Stem Cell Type as Key Biological Driver of Age-Related Belly Fat
3 sources · 26d ago
Factlen Explainer
First-Ever Oral Epinephrine Tablet Approved for Emergency Treatment of Severe Allergic Reactions
3 sources · 26d ago
Factlen Explainer
Landmark Study Finds Blood Test Can Predict Alzheimer's Risk Up to 25 Years Before Symptoms
3 sources · 26d ago
More in Health
Factlen ResearchMetastatic Breast Cancer
FDA Approves Palbociclib to Significantly Extend Progression-Free Survival in HR+/HER2+ Metastatic Breast Cancer
Clinical Oncologists 40%Breast Cancer Researchers 35%Health Economists & Payers 25%
6 sources · 26d ago
Factlen ExplainerMetabolic Health
How a 20-Year NIH Trial Proved Lifestyle Changes Outperform Metformin for Long-Term Health
Preventive Medicine Advocates 40%Pharmacological Researchers 35%Health Economists 25%
4 sources · 26d ago
Factlen ExplainerAutoimmune Breakthrough
The Evidence Pack: How CAR-T Cell Therapy is 'Resetting' the Immune System in Severe Autoimmune Diseases
Clinical Researchers 40%Patient Advocates 30%Biotech Developers 30%
5 sources · 26d ago
AcromegalyExplainer
FDA Approves Paltusotine as the First Once-Daily Oral Treatment for Acromegaly
Patients & Advocacy Groups 40%Endocrinologists & Clinicians 35%Pharmaceutical Developers 25%
6 sources · 26d ago
AcromegalyExplainer
FDA Approves Paltusotine as the First Once-Daily Oral Treatment for Acromegaly
Patients & Advocacy Groups 40%Endocrinologists & Clinicians 35%Pharmaceutical Developers 25%
6 sources · 26d ago
Factlen ExplainerNature Therapy
The Evidence Pack: How 'Forest Bathing' Measurably Lowers Cortisol and Boosts Immune Function
Clinical Researchers 45%Public Health Advocates 35%Factlen Analysis 20%
4 sources · 26d ago
Factlen ExplainerNature Therapy
The Evidence Pack: How 'Forest Bathing' Measurably Lowers Cortisol and Boosts Immune Function
Clinical Researchers 45%Public Health Advocates 35%Factlen Analysis 20%
4 sources · 26d ago
Factlen Deep DiveGenetic Medicine
The Evidence Pack: How the FDA-Approved Gene Therapy Otarmeni Restores Hearing in Genetic Deafness
Medical Researchers 40%Deaf Culture Advocates 30%Healthcare Payers 30%
4 sources · 26d ago
XenotransplantationExplainer
How Gene-Edited Pig Kidneys Are Moving From Experimental Surgery to Clinical Reality
Transplant Researchers 40%Biotech Developers 35%Bioethicists & Patient Advocates 25%
4 sources · 26d ago
Factlen ExplainerDMD Cell Therapy
The Evidence Pack: How Deramiocel's Five-Year Data is Reshaping Duchenne Muscular Dystrophy Treatment
DMD Patients & Advocacy Groups 35%Pediatric Neurologists & Cardiologists 35%Biotech & Regulatory Analysts 30%
4 sources · 27d ago
Factlen ExplainerDMD Cell Therapy
The Evidence Pack: How Deramiocel's Five-Year Data is Reshaping Duchenne Muscular Dystrophy Treatment
DMD Patients & Advocacy Groups 35%Pediatric Neurologists & Cardiologists 35%Biotech & Regulatory Analysts 30%
4 sources · 27d ago
Factlen Deep DiveLongevity Medicine
Major Human Trial Launches to Test Three FDA-Approved Drugs for Healthspan and New Regulatory Endpoint
Geroscience Researchers 40%Regulatory Pragmatists 35%Clinical Skeptics 25%
5 sources · 27d ago
Factlen Deep DiveLongevity Medicine
Major Human Trial Launches to Test Three FDA-Approved Drugs for Healthspan and New Regulatory Endpoint
Geroscience Researchers 40%Regulatory Pragmatists 35%Clinical Skeptics 25%
5 sources · 27d ago
Breast CancerExplainer
FDA Grants Full Approval to Datopotamab Deruxtecan for Metastatic Triple-Negative Breast Cancer
Clinical Investigators 47%Regulatory Authorities 35%Industry Developers 18%
4 sources · 27d ago
Breast CancerExplainer
FDA Grants Full Approval to Datopotamab Deruxtecan for Metastatic Triple-Negative Breast Cancer
Clinical Investigators 47%Regulatory Authorities 35%Industry Developers 18%
4 sources · 27d ago
Factlen ResearchNetwork Medicine
The Evidence Pack: How a Common Nasal Spray Emerged as a Computational Anti-Aging Candidate
Network Medicine Researchers 40%Clinical Pharmacologists 40%Geroscience Advocates 20%
4 sources · 27d ago
Factlen ExplainerRespiratory Health
FDA Approves Ohtuvayre, the First COPD Drug with a Novel Mechanism in Over Two Decades
Clinical Researchers 40%Patient Advocates 30%Regulatory & Industry Analysts 30%
4 sources · 27d ago
Factlen ExplainerAntibiotic Resistance
FDA Approves Utebzi, the First Oral Carbapenem Antibiotic for Complicated Urinary Tract Infections
Infectious Disease Specialists 41%Antimicrobial Stewardship Advocates 35%Pharmaceutical Developers 24%
3 sources · 27d ago
Factlen ExplainerCOVID-19 Prevention
FDA Approves Xocova, the First Oral Antiviral Pill for COVID-19 Post-Exposure Prevention
Infectious Disease Specialists 41%Pharmacologists 35%Public Health Officials 24%
6 sources · 27d ago
Factlen ExplainerViral Hepatitis
FDA Approves First-Ever Treatment for Hepatitis Delta Virus, the World's Most Dangerous Form of Viral Hepatitis
Clinical Researchers & Practitioners 44%Regulatory & Public Health Authorities 33%Patient Advocacy Organizations 22%
6 sources · 27d ago
Factlen ExplainerViral Hepatitis
FDA Approves First-Ever Treatment for Hepatitis Delta Virus, the World's Most Dangerous Form of Viral Hepatitis
Clinical Researchers & Practitioners 44%Regulatory & Public Health Authorities 33%Patient Advocacy Organizations 22%
6 sources · 27d ago
Factlen ExplainerSmoking Cessation
FDA Nears Approval of Cytisinicline, the First New Non-Nicotine Smoking Cessation Pill in Two Decades
Addiction Medicine Specialists 40%Public Health Advocates 35%Pharmacological Researchers 25%
6 sources · 27d ago
Factlen ExplainerSmoking Cessation
FDA Nears Approval of Cytisinicline, the First New Non-Nicotine Smoking Cessation Pill in Two Decades
Addiction Medicine Specialists 40%Public Health Advocates 35%Pharmacological Researchers 25%
6 sources · 27d ago
Factlen ExplainerProstate Cancer
Landmark Trial Finds Apalutamide Combo Cuts Metastasis Risk in High-Risk Localized Prostate Cancer
Clinical Oncologists 45%Patient Advocacy Groups 35%Health Economists 20%
7 sources · 27d ago
Factlen ExplainerProstate Cancer
Landmark Trial Finds Apalutamide Combo Cuts Metastasis Risk in High-Risk Localized Prostate Cancer
Clinical Oncologists 45%Patient Advocacy Groups 35%Health Economists 20%
7 sources · 27d ago